Eventide Asset Management - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 206 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,285,708
-57.1%
261,360
-43.1%
0.11%
-54.4%
Q2 2023$14,662,352
+4.3%
459,2030.0%0.25%
-3.9%
Q1 2023$14,060,796
+34.6%
459,203
+72.0%
0.26%
+25.2%
Q4 2022$10,443,348
-17.9%
267,0250.0%0.21%
-17.6%
Q3 2022$12,721,000267,0250.25%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,346,934$56,443,76354.70%
HSG Holding Ltd 796,089$19,145,9402.05%
Redmile Group, LLC 1,469,725$35,346,8861.68%
ARK Investment Management 8,783,891$211,252,5901.62%
Casdin Capital, LLC 570,000$13,708,5001.52%
Deep Track Capital, LP 1,015,641$24,426,1660.94%
Yiheng Capital Management, L.P. 560,500$13,480,0250.69%
Temasek Holdings (Private) Ltd 4,317,789$103,842,8250.62%
FARALLON CAPITAL MANAGEMENT LLC 4,481,839$107,788,2280.54%
Alphabet Inc. 321,604$7,734,5760.50%
View complete list of BEAM THERAPEUTICS INC shareholders